berberine has been researched along with Hyperhomocysteinemia in 3 studies
Hyperhomocysteinemia: Condition in which the plasma levels of homocysteine and related metabolites are elevated (
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine can counteract HFD-elicited hyperhomocysteinemia and hyperlipidemia partially via upregulating LDLR and apoE mRNA levels and suppressing HMGR gene expression." | 7.78 | The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet. ( Bian, H; Chang, XX; Gao, X; Xia, MF; Xu, Q; Yan, HM; Zhu, TF, 2012) |
| "Hyperhomocysteinemia, an elevation of blood homocysteine levels, is a metabolic disorder associated with dysfunction of multiple organs." | 7.77 | Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia. ( O, K; Sarna, LK; Siow, YL; Wu, N, 2011) |
| "Berberine increases atherosclerotic plaque stability in hyperhomocysteinemia mice, which is related to the activation of peroxisome proliferator-activated receptor-γ and subsequent suppression of oxidative stress in endothelial cells." | 3.83 | Berberine activates peroxisome proliferator-activated receptor gamma to increase atherosclerotic plaque stability in Apoe ( Fang, L; He, C; Li, H; Li, X; Liu, N; Sun, X; Wang, J; Yang, Z, 2016) |
| "Berberine can counteract HFD-elicited hyperhomocysteinemia and hyperlipidemia partially via upregulating LDLR and apoE mRNA levels and suppressing HMGR gene expression." | 3.78 | The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet. ( Bian, H; Chang, XX; Gao, X; Xia, MF; Xu, Q; Yan, HM; Zhu, TF, 2012) |
| "Hyperhomocysteinemia, an elevation of blood homocysteine levels, is a metabolic disorder associated with dysfunction of multiple organs." | 3.77 | Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia. ( O, K; Sarna, LK; Siow, YL; Wu, N, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H | 1 |
| He, C | 1 |
| Wang, J | 1 |
| Li, X | 1 |
| Yang, Z | 1 |
| Sun, X | 1 |
| Fang, L | 1 |
| Liu, N | 1 |
| Wu, N | 1 |
| Sarna, LK | 1 |
| Siow, YL | 1 |
| O, K | 1 |
| Chang, XX | 1 |
| Yan, HM | 1 |
| Xu, Q | 1 |
| Xia, MF | 1 |
| Bian, H | 1 |
| Zhu, TF | 1 |
| Gao, X | 1 |
3 other studies available for berberine and Hyperhomocysteinemia
| Article | Year |
|---|---|
Berberine activates peroxisome proliferator-activated receptor gamma to increase atherosclerotic plaque stability in Apoe
Topics: Animals; Apolipoproteins E; Berberine; Carotid Arteries; Cell Survival; Cells, Cultured; Disease Mod | 2016 |
Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia.
Topics: Alanine Transaminase; AMP-Activated Protein Kinases; Animals; Aspartate Aminotransferases; Berberine | 2011 |
The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet.
Topics: Animals; Aorta; Apolipoproteins; Atherosclerosis; Berberine; Cholesterol; Cholesterol, LDL; Diet, Hi | 2012 |